OcuCell Receives Funding from the Georgia Eye Bank
OcuCell, a provider of ocular cell therapy, has announced funding from the Georgia Eye Bank. Established in 1961, the Georgia Eye Bank has contributed over 60,000 corneas for transplantation, demonstrating a commitment to enhancing vision and enriching lives through the transplantation of ocular tissue and cells.
The financial details of the agreement have not been disclosed.
Alongside this funding, Eric Meinecke, President, and CEO of the Georgia Eye Bank, will assume a position on the OcuCell Board of Directors, while William Barry Lee, MD, Co-Medical Director, will join the OcuCell Scientific Advisory Board.
“Georgia Eye Bank has a long and proud history of serving others,” Mr. Meinecke said in an OcuCell news release. “Our organization believes strongly in innovation and collaboration. We are thrilled to be working with OcuCell and looking forward to contributing to its growth and success.”
“Georgia Eye Bank’s investment not only validates our commitment to excellence, but also strengthens our financial footing as we embark on the next phase of ocular cell therapy product development,” said OcuCell President and Co-Founder Chris Stoeger. “We are excited to welcome them and know their extensive knowledge in the eye banking and ocular industry align perfectly with our vision to provide state-of-the-art ocular cell therapy solutions that improve lives.”
OcuCell expressed its commitment to actively seeking partnerships and collaborations with industry stakeholders, research institutions, and healthcare partners.
